You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Graft-Versus-Host Disease Prophylaxis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD Trial in Shenzhen, Shanghai (PTCY)

Not yet recruiting
  • GVHD
  • Shenzhen, GaungDong, China
  • +1 more
Aug 17, 2023

The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)

Not yet recruiting
  • The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
  • Ruxolitinib 5 MG BID Oral Tablet
  • (no location specified)
Jun 13, 2023

Graft-versus-host-disease, CMV Trial (Letermovir)

Not yet recruiting
  • Graft-versus-host-disease
  • CMV
  • (no location specified)
Jul 23, 2023

GVHD Trial in Detroit (uhCG/EGF)

Recruiting
  • Graft Versus Host Disease
  • Detroit, Michigan
    Henry Ford Hospital
Dec 23, 2021

Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation Trial run by the National Cancer Institute

Not yet recruiting
  • Peripheral Blood Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)

Not yet recruiting
  • Graft Vs Host Disease
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Aug 18, 2023

Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)

Not yet recruiting
  • Graft-versus-host Disease
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

GVHD, Malignancy Trial in Canada, United States (Abatacept, )

Active, not recruiting
Has Results
  • Graft vs Host Disease
  • Malignancy
  • Los Angeles, California
  • +13 more
Jan 9, 2023

GVHD Trial in Nantes (drug, radiation, other)

Terminated
  • Graft Versus Host Disease
  • Nantes, France
    Nantes Uh
Jul 13, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (Biospecimen Collection, Chest

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • Biospecimen Collection
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Nov 9, 2023

Graft-versus-host-disease, Graft Vs Host Disease Trial in Saint Louis (Baricitinib)

Recruiting
  • Graft-versus-host-disease
  • Graft Vs Host Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 4, 2022

GVHD, Hematologic Malignancy, Cyclophosphamide Adverse Reaction Trial (Post-transplantation Cyclophosphamide at dose 25

Not yet recruiting
  • Graft Versus Host Disease
  • +2 more
  • Post-transplantation Cyclophosphamide at dose 25 mg/kg/day
  • Post-transplantation Cyclophosphamide at dose 50 mg/kg/day
  • (no location specified)
Dec 17, 2021

Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, MDS Trial in Saint Petersburg (Bendamustine Hydrochloride, Cyclophosphamid)

Recruiting
  • Myeloid Leukemia, Acute
  • +3 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
Apr 4, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Successful Cyclosporine Acute GVHD Prophylaxis in Children

Completed
  • Acute-graft-versus-host Disease
    • Toronto, Ontario, Canada
      Hospital for Sick Children
    Aug 12, 2021

    GVHD, Hematologic Tumors Trial in La Jolla (Cyclophosphamide, abatacept, Methotrexate)

    Recruiting
    • GVHD
    • Hematologic Neoplasms
    • La Jolla, California
      UC San Diego Moores Cancer Center
    Mar 21, 2022

    Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)

    Recruiting
    • Acute Myelogenous Leukemia
    • +4 more
    • Stem cell transplantation
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 23, 2022

    GVHD Trial in Hangzhou (Ruxolitinib+Calcineurin +Methotrexate, Calcineurin +Methotrexate+Mycophenolate mofetil)

    Recruiting
    • Graft Versus Host Disease
    • Ruxolitinib+Calcineurin +Methotrexate
    • Calcineurin +Methotrexate+Mycophenolate mofetil
    • Hangzhou, Zhejiang, China
      The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
    Apr 8, 2021

    Graft-versus-host-disease, Relapse Trial in Calgary (Treatment Arm - high dose ATG, Control Arm - standard of care)

    Recruiting
    • Graft-versus-host-disease
    • Relapse
    • Treatment Arm - high dose ATG
    • Control Arm - standard of care
    • Calgary, Alberta, Canada
      Tom Baker Cancer Centre
    Oct 14, 2022

    Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)

    Recruiting
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma
    • Badalona, Spain
    • +7 more
    May 20, 2022

    Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg

    Recruiting
    • Graft-versus-host-disease
    • +3 more
    • Moscow, Russian Federation
    • +1 more
    Apr 4, 2022

    Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders Trial in New Haven, Saint Louis (RIC regimen,

    Recruiting
    • Severe Sickle Cell Disease
    • +5 more
    • RIC regimen
    • GVHD prophylaxis regimen
    • New Haven, Connecticut
    • +1 more
    Feb 4, 2022

    Acute-graft-versus-host Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Suzhou (Sitagliptin + Standard

    Recruiting
    • Acute-graft-versus-host Disease
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Sitagliptin + Standard Prophylaxis
    • Standard Prophylaxis
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University, Jiangsu Ins
    Jan 13, 2022

    Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

    Recruiting
    • Graft Vs Host Disease
    • +5 more
    • Augsburg, Germany
    • +15 more
    Aug 2, 2022